Search Ontology:
ChEBI

doxercalciferol

Term ID
CHEBI:4712
Synonyms
  • (1S,3R,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraene-1,3-diol
  • 1-alpha-hydroxyvitamin D2
  • 1alpha-hydroxyergocalciferol
  • 1alpha-hydroxyvitamin D2
  • doxercalciferol
  • doxercalciferolum
  • Hectorol
Definition
A hydroxy seco-steroid and synthetic vitamin D2 analogue that undergoes metabolic activation in vivo to form 1α,25-dihydroxyvitamin D2 (1α,25-(OH)2D2), a naturally occurring, biologically active form of vitamin D2. It is used to treat secondary hyperparathyroidism, a condition in which the body produces excess parathyroid hormone (PTH; a natural substance needed to control the amount of calcium in the blood) in certain people with chronic kidney disease.
References
  • cas:54573-75-0
  • drugbank:DB06410
  • drugcentral:957
  • kegg.compound:C08211
  • kegg.drug:D01009
  • pdb-ccd:V2H
  • pubmed:12227689
  • pubmed:12834181
  • pubmed:17603751
  • pubmed:21155068
  • pubmed:21849802
  • pubmed:22123370
  • pubmed:23780943
  • pubmed:25774916
  • pubmed:28586017
  • wikipedia.en:Doxercalciferol
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from doxercalciferol
Phenotype where environments contain doxercalciferol
Phenotype modified by environments containing doxercalciferol
Phenotype affecting doxercalciferol
Human Disease Model